Viewing Study NCT06340958


Ignite Creation Date: 2025-12-25 @ 12:22 AM
Ignite Modification Date: 2025-12-25 @ 10:27 PM
Study NCT ID: NCT06340958
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-30
First Post: 2024-03-25
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of CLE-100 (Oral Esketamine) as an Adjunctive Treatment to Standard Antidepressants for Major Depressive Disorder
Sponsor: Clexio Biosciences Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module